Effect of Cheese on Cardiovascular Risk (ECCA)

November 20, 2014 updated by: Arne Astrup, University of Copenhagen

The main objective of the current study is to examine whether a high intake of regular-fat cheeses (Danbo and Cheddar) affect blood lipids differently than an isocaloric intake of either other fatty animal food products or of starchy carbohydrates. Furthermore, effects on fat digestibility, blood pressure, anthropometry, bile acid metabolism and insulin sensitivity is investigated.

To do this, a randomized crossover intervention study with 3x14 days full diet periods (cheese diet, meat diet or carb diet)will be conducted in 16 postmenopausal women. Between the diet periods there will be at least 14 days of wash-out where the subjects eat their habitual diets. Fasting blood samples will be drawn before and after the diet periods, and also a non-fasting blood sample will be drawn after the diet periods. Furthermore, total feces is collected the last 5 days of each diet period.

Study Overview

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Frederiksberg
      • Copenhagen, Frederiksberg, Denmark, 1958
        • Department of Nutrition, Exercise and Sports

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 68 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female gender
  • Postmenopausal for >1 year
  • Age 45-68 years
  • BMI 25-32 kg/m2
  • TC > 4.5 mmol/L and < 7 mmol/L
  • Systolic blood pressure <160 mmHg and/or diastolic blood pressure <100 mmHg

Exclusion Criteria:

  • Chronic diseases (known diabetes; CVD; other chronic diseases which could affect the results of the present study)
  • Milk allergy
  • Nut allergy
  • Use of dietary supplements incl. multivitamins (2 months before and during the entire study period)
  • Smoking
  • Elite athletes (>10 hours of strenuous physical activity per week)
  • Use of prescription medicine which could affect the results of the present study including systemic glucocorticoids
  • Use of lipid-lowering agents
  • Stable dose of antihypertensive medication >3 months before study commencement for subjects with high blood pressure
  • Hormone replacement therapy
  • Blood donation <1 month before study commencement and during study period
  • Simultaneous participation in other clinical studies
  • Inability (physically or psychologically) to comply with the procedures required by the protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CARB diet
The CARB diet will be a low-fat diet where cheese is replaced by starchy carbohydrates and lean meat. The CARB diet will have the same protein content (15 E%) and quality as the CHEESE and MEAT diet but a lower fat content (approx. 25 E%) and a correspondingly higher carbohydrate content (approx. 60 E%).
Experimental: CHEESE diet
The CHEESE diet will contain cheese in amounts corresponding to 120 g/day on a 10 MJ diet (approx. 1.8 MJ from cheese). A high dose of cheese is chosen to provoke effects within this short time frame. The cheese types used in this study will be Danbo (45+) and Cheddar (50+) which will be supplied in equal amounts. The CHEESE diet will have the same macronutrient composition as that of the average Danish diet (15 E% from protein, max 35 E% from fat, and max 15 E% from saturated fat).
Experimental: MEAT diet
The MEAT diet will be a diet without dairy products. In this diet cheese is mainly replaced by high-fat mixed meat products to achieve saturated fat content and protein quality similar to that of the CHEESE diet. The MEAT diet will have the same macronutrient composition as that of the average Danish diet (15 E% from protein, max 35 E% from fat, and max 15 E% from saturated fat).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
LDL cholesterol
Time Frame: day 1 and day 14 in each diet period
fasting, mmol/l
day 1 and day 14 in each diet period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood lipid concentrations
Time Frame: day 1 and day 14 in each diet period

Total cholesterol and HDL cholesterol. Fasting, mmol/l.

Triglycerides. Fasting and non-fasting, mmol/l

day 1 and day 14 in each diet period
ApoA1 and ApoB
Time Frame: day 1 and day 14 in each diet period
day 1 and day 14 in each diet period
Dietary fat digestibility
Time Frame: During day 10-14 in each period

Fecal fat and energy excretion.

Total excretion of fecal fat (grams/day) and energy (kJ/day) averaged over five days

During day 10-14 in each period
Blood pressure
Time Frame: day 1 and day 14 in each diet period
mmHg
day 1 and day 14 in each diet period
Anthropometry
Time Frame: day 1 and day 14 in each diet period
waist to hip ratio, waist circumference and body weight
day 1 and day 14 in each diet period
Insulin sensitivity
Time Frame: day 1 and 14 in each diet period
Fasting and non-fasting glucose and insulin
day 1 and 14 in each diet period
Bile acid metabolism
Time Frame: day 14 of each intervention period
Serum alpha-HC, fecal bile acid excretion
day 14 of each intervention period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

August 1, 2013

Study Completion (Actual)

November 1, 2014

Study Registration Dates

First Submitted

November 27, 2012

First Submitted That Met QC Criteria

November 27, 2012

First Posted (Estimate)

December 3, 2012

Study Record Updates

Last Update Posted (Estimate)

November 21, 2014

Last Update Submitted That Met QC Criteria

November 20, 2014

Last Verified

November 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hyperlipidemia

Clinical Trials on Dietary intervention: CARB (High Carbohydrate intake)

3
Subscribe